Carilex Medical, Inc.

NT$30.95As of Sun 8 Nov 2026, 12:00 UTC

TPEx:7726Healthcare

Country Taiwan

PE (Fwd) —

TSR 3Y CAGR (19.98%)

Div yield —

ROE (9.33%)

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM (18.55%)

Mkt cap NT$628.4M

ROIC (16.98%)

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

NT$32

3.39%

(77.26%)

Price above Reference Value

TTM

FYE 31 Dec TWD

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

338.6

RevenueNT$M

—

335.3

466.4

351.7

338.6

360.5

0.33%

—

(3.72)

Revenue growth%

—

39.08

(24.58)

(3.72)

6.45

(3.72)

—

29.27

Gross margin%

—

42.54

42.19

42.78

29.27

29.25

42.36

—

(12.63)

Operating margin%

—

5.24

11.88

0.86

(12.63)

(12.21)

3.05

—

(8.56)

Net margin%

—

8.61

9.53

3.83

(8.56)

(8.50)

6.22

—

P/E ratio (avg)x

—

78.13

—

78.13

—

EV/EBITx

—

326.4

—

326.4

—

5.74

FCF yield (avg)%

—

2.09

4.36

6.02

3.23

—

10.64

FCF margin%

—

1.45

(1.01)

6.27

10.64

10.49

3.86

—

(1.244)

FCF / Net incomex

—

0.168

(0.106)

1.636

(1.244)

—

0.031

—

(16.98)

ROIC%

—

9.01

24.85

1.17

(16.98)

(21.52)

5.09

—

(9.33)

Return on equity%

—

12.17

15.10

3.95

(9.33)

(11.12)

8.06

—

(5.43)

Return on assets%

—

6.96

8.18

2.93

(5.43)

(6.09)

4.95

—

(1.43)

EPSNT$

—

1.69

2.44

0.66

(1.43)

(1.51)

(37.36%)

—

(315.80)

EPS growth%

—

44.67

(72.88)

(315.80)

(5.73)

(72.88)

—

14.33

Bookvalue per shNT$

—

13.85

19.29

16.20

14.33

12.82

1.13%

—

1.78

FCF per shareNT$

—

0.28

(0.26)

1.08

1.78

1.86

84.27%

—

Dividend per shNT$

—

Div yield (avg)%

—

Payout ratio%

—

20.30

Shares (diluted)M

—

17.12

18.22

20.38

20.30

◌20.30

5.85%

—

0.35

Buyback yield%

—

(6.44)

(11.81)

0.35

◌—

(6.44)

—

0.592

D/E ratiox

—

0.368

0.206

0.218

0.592

0.661

0.293

—

576.3

Enterprise valueNT$M

—

987.7

774.8

538.5

(21.55%)

—

LT debtNT$M

—

Peers (US$19.72M)

Cap (US$)

Diamond Biotechnology…

22.90M

—

Cowealth Medical…

20.80M

—

PlexBio Co., Ltd.

18.22M

—

Cheelcare Inc.

19.79M

—

Capital

TTM

10Y

Leveragex

—

(1.324)

EBIT/Intx

(17.04)

7.476

Own earn%

—

Sh yield%

0.35

(6.44)

Owners

Insiders/Inst%

11.02

1.54

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

3/4

Revenue growth years

1/3

EPS growth years

1/3

Dividend streakyrs

Op margin range%

−13–12

$1 testx

—

Incr. ROIC%

−138

Carilex Medical, Inc. engages in the research and development, manufacture, and sale of medical devices for wound care management worldwide. It offers support surfaces, chair cushions, and negative pressure wound therapy products to prevent and manage pressure sores and wounds. The company was founded in 1985 and is headquartered in Taoyuan City, Taiwan.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

NT$338.6M

0.33%

1.00×

Cost of revenue

NT$239.5M

7.52%

1.23×

Operating expenses

NT$141.9M

4.29%

1.12×

Asset mix

Trend

Other

58.00%

Cash and investments

42.00%

Reinvestment returns

No breakdown available